Trending

#KEYNOTE630study

Latest posts tagged with #KEYNOTE630study on Bluesky

Latest Top
Trending

Posts tagged #KEYNOTE630study

Preview
Regeneron's Libtayo stakes out new territory in skin cancer Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

#Regeneron #Libtayo #cemiplimab #skincancer #Squamouscellcarcinoma #checkpointinhibitor #FDA #cutaneoussquamouscellcarcinoma #CSCC #basalcellcarcinoma #nonsmallcelllungcancer #cervicalcancer #highriskCSCC #KEYNOTE630study #CPOSTstudy #Libtayotreatedpatients #PD1PDL1inhibitors
zurl.co/9toKK

0 0 0 0